secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001628908-24-000051
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health Q1 revenue $639.7M (+49.6% YoY); raises FY2024 revenue guide
---------------------------------------------------------------------------

- Revenue $639.7M, net loss $(25.2)M; Adjusted EBITDA $54.1M (8.5% margin).
- Raises full-year 2024 revenue outlook; reiterates Adjusted EBITDA and exit-rate guidance.
- Ends NIA transition services agreement; partners with Careology to accelerate patient navigation.
- New Performance Suite with Molina for oncology/cardiology in SC and MS; MSK contract with east coast Medicaid plan.
- Performance Suite average lives 7,050 (up from 3,242 YoY); specialty care revenue grew over 60%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890824000051/0001628908-24-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890824000051/evh-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001628908-24-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer